Share
Share today's newsletter with a colleague and get credit if they sign up for SmartBrief.
Referral Count:
 
3

Story being shared
Genetic screening helps early trials of cancer drugs
More efficient early-stage studies, advanced genetic screening and the need for better drugs have helped a few cancer treatments obtain faster approval in the past two years. "We hope to be able to shave years off the time it takes to get final approval and save hundreds of millions of dollars per drug," the New York University Cancer Institute's Robert Schneider said.

Or we can send an email on your behalf
You must submit valid email addresses only. Use of email addresses is subject to terms of SmartBrief's privacy policy .